Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
scientific article published on 21 February 2012
Author/s
author: Hagop Kantarjian, Stefan Faderl, Jorge Eduardo Cortes, Susan O'Brien, Farhad Ravandi, Elias Jabbour, Mary Beth Rios, Luis E. Fayad, Jeffrey C. Jorgensen, Richard E Champlin, Partow Kebriaei, Michael E Rytting, Monica Kwari, Sergernne York, Anjali S Advani
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.